{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:49:21Z","timestamp":1793155761302,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Maturity Onset Diabetes of the Young (MODY) is a monogenic, autosomal, dominant disease that results in beta-cells dysfunction with consequent hyperglycaemia. It represents a rare form of diabetes (1\u20132% of all the cases).<\/jats:p>\n                <jats:p>Sulphonylureas (SUs) represent the first-line treatment for this form of diabetes mellitus.<\/jats:p>\n                <jats:p>NEUROD1 is expressed by the nervous and the pancreatic tissues, and it is necessary for the proper development of beta cells. A neurogenic differentiation factor 1 (NEUROD1) gene mutation causes beta-cells dysfunction, inadequate insulin secretion, and hyperglycaemia (MODY 6).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We have documented a new missense mutation (p.Met114Leu c.340A\u2009&gt;\u2009C) of the NEUROD1 gene, pathogenetic for diabetes mellitus, in a 48\u2009years-old man affected by diabetes since the age of 25 and treated with insulin basal-bolus therapy. Unfortunately, an attempt to replace rapid insulin with dapagliflozin has failed. However, after the genetic diagnosis of MODY6 and treatment with SUs, he was otherwise able to suspend rapid insulin and close glucose monitoring. Interestingly, our patient had an early onset dilated cardiomyopathy, though no data about cardiac diseases in patients with MODY 6 are available.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Diagnostic criteria for MODY can overlap with other kinds of diabetes and most cases of genetic diabetes are still misdiagnosed as diabetes type 1 or 2. We encourage to suspect this disease in patients with a strong family history of diabetes, normal BMI, early-onset, and no autoimmunity. The appropriate therapy simplifies disease management and improves the quality of the patient\u2019s life.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-021-00864-w","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T20:24:15Z","timestamp":1634329455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["NEUROD1 mutation in an Italian patient with maturity onset diabetes of the young 6: a case report"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7735-7847","authenticated-orcid":false,"given":"Lucia","family":"Brodosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Baracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilma","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Pironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"864_CR1","volume-title":"StatPearls","author":"A Sapra","year":"2020","unstructured":"Sapra A, Bhandari P. Diabetes mellitus. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020. PMID: 31855345."},{"key":"864_CR2","first-page":"193","volume":"74","author":"H Heuvel-Borsboom","year":"2016","unstructured":"Heuvel-Borsboom H, de Valk HW, Losekoot M, Westerink J. Maturity onset diabetes of the young: seek and you will find. Neth J Med. 2016;74:193\u2013200.","journal-title":"Neth J Med"},{"key":"864_CR3","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2147\/DMSO.S179793","volume":"12","author":"T Urakami","year":"2019","unstructured":"Urakami T. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes MetabSyndrObes. 2019;12:1047\u201356. https:\/\/doi.org\/10.2147\/DMSO.S179793.","journal-title":"Diabetes MetabSyndrObes"},{"key":"864_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jcjd.2015.12.005","volume":"40","author":"J Timsit","year":"2016","unstructured":"Timsit J, Saint-Martin C, Dubois-Laforgue D, Bellann\u00e9-Chantelot C. Searching for maturity-onset diabetes of the young (MODY): when and what for? Can J Diabetes. 2016;40:455\u201361. https:\/\/doi.org\/10.1016\/j.jcjd.2015.12.005.","journal-title":"Can J Diabetes"},{"key":"864_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-3-030-25905-1_18","volume":"111","author":"Z Ga\u00e1l","year":"2019","unstructured":"Ga\u00e1l Z, Balogh I. Monogenic forms of diabetes mellitus. Exp Suppl. 2019;111:385\u2013416. https:\/\/doi.org\/10.1007\/978-3-030-25905-1_18.","journal-title":"Exp Suppl"},{"key":"864_CR6","volume-title":"Diabetes, maturity onset in the young (MODY). In: StatPearls","author":"LS Hoffman","year":"2020","unstructured":"Hoffman LS, Jialal I. Diabetes, maturity onset in the young (MODY). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020. 30422495."},{"key":"864_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11892-015-0681-7","volume":"15","author":"JW Kleinberger","year":"2015","unstructured":"Kleinberger JW, Pollin TI. Undiagnosed MODY: Time for action. Curr Diab Rep. 2015;15:110. https:\/\/doi.org\/10.1007\/s11892-015-0681-7.","journal-title":"Curr Diab Rep"},{"key":"864_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4093\/dmj.2015.39.6.468","volume":"39","author":"SH Kim","year":"2015","unstructured":"Kim SH. Maturity-onset diabetes of the young: what do clinicians need to know? Diabetes Metab J. 2015;39:468\u201377. https:\/\/doi.org\/10.4093\/dmj.2015.39.6.468.","journal-title":"Diabetes Metab J"},{"key":"864_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/MOP.0000000000000643","volume":"30","author":"AG Harris","year":"2018","unstructured":"Harris AG, Letourneau LR, Greeley SAW. Monogenic diabetes: the impact of making the right diagnosis. CurrOpinPediatr. 2018;30:558\u201367. https:\/\/doi.org\/10.1097\/MOP.0000000000000643.","journal-title":"CurrOpinPediatr."},{"key":"864_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/pedi.12931","volume":"21","author":"EB Tatsi","year":"2020","unstructured":"Tatsi EB, Kanaka-Gantenbein C, Scorilas A, Chrousos GP, Sertedaki A. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy. Pediatr Diabetes. 2020;21:28\u201339. https:\/\/doi.org\/10.1111\/pedi.12931.","journal-title":"Pediatr Diabetes"},{"key":"864_CR11","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jmb.2019.08.016","volume":"432","author":"E De Franco","year":"2020","unstructured":"De Franco E. From biology to genes and Back again: gene discovery for monogenic forms of Beta-cell dysfunction in diabetes. J Mol Biol. 2020;432:1535\u201350. https:\/\/doi.org\/10.1016\/j.jmb.2019.08.016.","journal-title":"J Mol Biol"},{"key":"864_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11892-019-1202-x","volume":"19","author":"M Vaxillaire","year":"2019","unstructured":"Vaxillaire M, Froguel P, Bonnefond A. How recent advances in genomics improve precision diagnosis and personalized Care of Maturity-Onset Diabetes of the young. Curr Diab Rep. 2019;19:79. https:\/\/doi.org\/10.1007\/s11892-019-1202-x.","journal-title":"Curr Diab Rep"},{"key":"864_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.gde.2018.04.006","volume":"50","author":"KR Owen","year":"2018","unstructured":"Owen KR. Monogenic diabetes in adults: what are the new developments? CurrOpin Genet Dev. 2018;50:103\u201310. https:\/\/doi.org\/10.1016\/j.gde.2018.04.006.","journal-title":"CurrOpin Genet Dev"},{"key":"864_CR14","doi-asserted-by":"publisher","first-page":"2333794X1987421","DOI":"10.1177\/2333794X19874215","volume":"6","author":"K Gordon","year":"2019","unstructured":"Gordon K, Yao M, Siegel R, Stackpole K. A Case of a 13-Year-Old Female With Maturity Onset Diabetes of the Young (MODY) Identified by School-Based Cardiovascular Screening. Glob Pediatr Health. 2019;6:2333794X19874215. https:\/\/doi.org\/10.1177\/2333794X19874215.","journal-title":"Glob Pediatr Health"},{"key":"864_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pcd.2019.06.001","volume":"14","author":"I Baldacchino","year":"2020","unstructured":"Baldacchino I, Pace NP, Vassallo J. Screening for monogenic diabetes in primary care. Prim Care Diabetes. 2020;14:1\u201311. https:\/\/doi.org\/10.1016\/j.pcd.2019.06.001.","journal-title":"Prim Care Diabetes"},{"key":"864_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11892-018-1024-2","volume":"18","author":"M Sanyoura","year":"2018","unstructured":"Sanyoura M, Philipson LH, Naylor R. Monogenic diabetes in children and adolescents: recognition and treatment options. Curr Diab Rep. 2018;18:58. https:\/\/doi.org\/10.1007\/s11892-018-1024-2.","journal-title":"Curr Diab Rep"},{"key":"864_CR17","doi-asserted-by":"publisher","unstructured":"Abreu GM, Tarantino RM, Cabello PH, Zembrzuski VM, da Fonseca A, Rodacki M, et al. The first case of NEUROD1-MODY reported in Latin America. Mol genet genomic. 2019; 7:e989. 2019. https:\/\/doi.org\/10.1002\/mgg3.989.","DOI":"10.1002\/mgg3.989"},{"key":"864_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pedi.12553","volume":"19","author":"Y Horikawa","year":"2018","unstructured":"Horikawa Y, Enya M, Mabe H, Fukushima K, Takubo N, Ohashi M, et al. NEUROD1-deficient diabetes (MODY6): identification of the first cases in Japanese and the clinical features. Pediatr Diabetes. 2018;19:236\u201342. https:\/\/doi.org\/10.1111\/pedi.12553.","journal-title":"Pediatr Diabetes"},{"key":"864_CR19","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2337\/db19-0117","volume":"68","author":"AI Romer","year":"2019","unstructured":"Romer AI, Singer RA, Sui L, Egli D, Sussel L. Murine perinatal \u03b2-cell proliferation and the differentiation of human stem cell-derived insulin-expressing cells require NEUROD1. Diabetes. 2019;68:2259\u201371. https:\/\/doi.org\/10.2337\/db19-0117.","journal-title":"Diabetes."},{"key":"864_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"issue":"20","key":"864_CR21","doi-asserted-by":"publisher","first-page":"30031","DOI":"10.1016\/j.diabet.2020.03.001","volume":"S1262\u20133636","author":"B Bouillet","year":"2020","unstructured":"Bouillet B, Crevisy E, Baillot-Rudoni S, Baillot-Rudoni S, Gallegarine D, Jouan T, et al. Whole-exome sequencing identifies the first French MODY 6 family with a new mutation in the NEUROD1 gene. Diabetes Metab. 2020;S1262\u20133636(20):30031\u20138. https:\/\/doi.org\/10.1016\/j.diabet.2020.03.001.","journal-title":"Diabetes Metab"},{"key":"864_CR22","doi-asserted-by":"publisher","first-page":"108867","DOI":"10.1016\/j.diabres.2021.108867","volume":"176","author":"LF Franco","year":"2021","unstructured":"Franco LF, Szarf G, Dotto RP, Dib SA, Moises RS, Giuffrida FMA, et al. Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations. Diabetes Res Clin Pract. 2021;176:108867. https:\/\/doi.org\/10.1016\/j.diabres.2021.108867.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"864_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/1753-0407.13097","volume":"13","author":"M Karaoglan","year":"2021","unstructured":"Karaoglan M, Nacarkahya G. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis. J Diabetes. 2021;13(2):154\u201363. https:\/\/doi.org\/10.1111\/1753-0407.13097.","journal-title":"J Diabetes"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00864-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-021-00864-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00864-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T20:27:37Z","timestamp":1634329657000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-021-00864-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1186\/s12902-021-00864-w","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"26 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written informed consent was obtained by the patient for the publication of his laboratory and clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}